U.S. Fertility Market Size is Expanding USD 8.69 Billion By 2033 (2024)

The U.S. fertility market size accounted for USD 5.34 billion in 2023 and is expanding to around USD 8.69 billion by 2033 with a registered CAGR of 4.78% from 2024 to 2033.

Key Takeaways

  • By offering, the assisted reproductive technology segment dominated the market in 2023.
  • By end-user, the fertility clinics segment dominated the U.S. fertility market in 2023 and the segment is observed to sustain the dominance throughout the forecast period.

Get the Sample Copy of This Report@ https://www.precedenceresearch.com/sample/3751

Market Overview

The U.S. fertility market stands as a pivotal segment within the broader healthcare landscape, encapsulating a multifaceted array of services, treatments, and technologies aimed at assisting individuals and couples in achieving their reproductive goals. With a steady rise in fertility-related concerns and an increasing emphasis on family planning, this market has garnered significant attention and undergone notable evolution over recent years.

Growth Factors

Advancements in Reproductive Medicine

Technological advancements in reproductive medicine have revolutionized the fertility industry, introducing cutting-edge treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and gamete intrafallopian transfer (GIFT). These innovations have significantly expanded the scope of fertility solutions available to patients, driving market growth.

Rising Awareness and Acceptance

Growing awareness and acceptance of fertility treatments have contributed to increased demand among individuals and couples facing difficulties conceiving. Shifts in societal norms and a greater willingness to discuss reproductive health issues openly have helped reduce stigma surrounding fertility treatments, thereby fueling market expansion.

Market Trends

Shift Towards Consumer-Centric Care

A notable trend within the fertility market is the shift towards consumer-centric care, characterized by personalized treatment approaches, transparent pricing models, and enhanced patient engagement initiatives. Providers are increasingly prioritizing patient-centered care delivery to foster trust, loyalty, and positive outcomes in a competitive healthcare landscape.

Embrace of Digital Health Solutions

The embrace of digital health solutions is reshaping the fertility market, with the proliferation of telemedicine platforms, mobile applications, and virtual care options facilitating remote consultations, monitoring, and support services. Leveraging digital technologies enables providers to extend their reach, optimize resource utilization, and improve patient convenience and accessibility.

In conclusion, the U.S. fertility market represents a dynamic and evolving sector driven by technological innovation, shifting demographics, and changing consumer preferences. While opportunities for growth abound, industry stakeholders must navigate regulatory challenges, address accessibility barriers, and adapt to emerging trends to thrive in a competitive landscape.

Market Dynamics


Delayed Parenthood Trends

Changing demographic patterns, including delayed parenthood among women pursuing higher education and career advancement, have led to a rise in age-related fertility challenges. As individuals postpone childbearing to later stages of life, the demand for fertility interventions to overcome age-related infertility has surged, acting as a significant driver for market growth.

Lifestyle Factors

Lifestyle factors such as stress, obesity, and environmental influences have been linked to fertility issues, prompting individuals to seek specialized interventions to optimize reproductive health. Consequently, the integration of lifestyle modification strategies within fertility treatment protocols has emerged as a key driver shaping the market landscape.


Expansion of Fertility Services

The expansion of fertility services presents a notable opportunity for market players to diversify their offerings and cater to evolving patient needs comprehensively. With the integration of ancillary services such as genetic testing, fertility preservation, and counseling, providers can enhance the overall patient experience and differentiate their practice in a competitive market environment.

Technological Innovations

Continued technological innovations in assisted reproductive technologies (ART) hold immense potential for driving market growth by improving treatment outcomes and expanding access to fertility care. Advancements in embryo screening techniques, artificial intelligence (AI) applications, and non-invasive fertility assessment tools offer promising avenues for enhancing clinical efficiency and patient satisfaction.


Regulatory Complexities

Navigating regulatory complexities and compliance requirements within the fertility market poses a significant challenge for industry stakeholders. The evolving regulatory landscape, encompassing licensure, accreditation, and ethical considerations, necessitates vigilant adherence to standards while ensuring continued innovation and access to care.

Affordability and Accessibility

Recommended by LinkedIn

Fertility Friday: Week of Nov 4 Ann Watson 4 years ago
It is time to remove "Elective" from "Elective… Alan B. Copperman, MD, FACOG 2 years ago
wawa fertility: working to improve fertility… wawa fertility 2 years ago

Affordability and accessibility remain persistent barriers to fertility care for many individuals, particularly those without adequate insurance coverage or financial resources. Addressing disparities in access to affordable treatment options and implementing initiatives to enhance affordability and insurance coverage represent crucial challenges facing the fertility market.

Recent Developments

  • In January 2024, the creative co-branding venture between Ivy Reproductive, an international center for family-building services, and SMP Pharmacy Solutions, a reproductive specialist pharmacy, aims to improve the patient experience at all 13 of Ivy's fertility centers.
  • In June 2023, Prominent ovarian biology-focused biotechnology company Celmatix Inc. has discovered encouraging early leads in its most recent therapeutic development, which aims to create the first oral FSH receptor (FSHR) agonist medication ever. The cutting-edge experimental product has the power to change infertility therapies completely.

Key Market Players

  • Boston IVF Fertility Clinic
  • INVO Bioscience
  • San Diego Fertility Center
  • Celmatix
  • Carolinas Fertility Institute
  • Progyny Inc.
  • Cook Medical

Segments Covered in the Report

By Offering

  • Assisted Reproductive TechnologyIVFArtificial InseminationSurrogacyOthers
  • Fertility DrugsGonadotropinAnti-estrogenOthers
  • Others

By End User

  • Fertility Clinics
  • Hospitals
  • Clinical Research Institutes

Unlocking Market Insights through Data Excellence

The "Precedence Statistics" flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today's dynamic and data-driven world.

Access our Premium Real-Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to contact atsales@precedenceresearch.com| +1 650 460 3308

U.S. Fertility Market Size is Expanding USD 8.69 Billion By 2033 (2024)


U.S. Fertility Market Size is Expanding USD 8.69 Billion By 2033? ›

The U.S. fertility market size was valued at USD 5.34 billion in 2023 and is anticipated to reach around USD 8.69 billion by 2033, poised to grow at a CAGR of 4.78% from 2024 to 2033.

Is infertility increasing in the US? ›

The percentage of married women ages 15–44 who were infertile rose from 6.7% in 2011–2015 to 8.7% in 2015–2019. Table A provides the estimated numbers of women with infertility or impaired fecundity in the U.S. household population over the periods 2011–2015 and 2015–2019.

How many IVF clinics are there in the US? ›

In the United States, about 500 clinics provide services to patients seeking to overcome infertility. CDC collects the data from all fertility clinics in the United States and calculates standardized success rates for each clinic.

How much money is the IVF industry worth? ›

According to Vision Research Reports, the global in vitro fertilization market size was estimated at USD 25.34 billion in 2023 and it is projected to hit around USD 43.57 billion by 2033 with a CAGR of 5.57% from 2024 to 2033.

Why do so many people struggle with infertility? ›

Causes of infertility can include ovulatory disorders, endometriosis, low sperm count or low testosterone. The risk of infertility increases as you age. Many treatment options are available for people with infertility.

Which country has the highest rate of infertility? ›

The highest and the lowest increase in the male infertility has been estimated in Asia (rate of 22.5) and Australia & Oceania (rate of 5.56). Moreover, female infertility in Asia and North American has the highest and the lowest increase rate of 10.18 vs 5.89, respectively.

What race has the highest fertility rate? ›

In the United States, the highest fertility rates (per 1,000 women ages 15-44) during 2020-2022 (average) were to Hispanic women (63.3), followed by Blacks (57.5), Whites (53.6), American Indian/Alaska Natives (51.4) and Asian/Pacific Islanders (50.6).

What percentage of babies are born by IVF? ›

“One thing that's helpful to know is just how common it is. About 2% of births in the US results from IVF. Over 8 million babies have been born using this technology.” Another technology important to the IVF process is cryopreservation of embryos — or freezing after the egg is fertilized.

Why is IVF so expensive in the United States? ›

Why is IVF so expensive? Prices for IVF are "significantly higher" than other options because of the many medical experts and procedures required to make it happen, Tang says. There's medication, an egg retrieval procedure done while the patient is under anesthesia, ultrasounds and lab work.

Which country has most IVF? ›

Denmark is widely recognized as a leading destination for IVF treatment, offering patients high-quality care and exceptional success rates. With its advanced healthcare system and supportive fertility legislation, Denmark has become a top choice for individuals and couples seeking assisted reproductive technologies.

Can the average person afford IVF? ›

The average cost for one cycle of in vitro fertilization (IVF) in the U.S. is $12,400. But, with medications and testing, you could pay as much as $30,000 for one IVF cycle. If you have health insurance, check to see if your plan covers some or all of the costs of IVF.

Where is the cheapest IVF in the world? ›

Turkey. Regarded as one of the cheaper countries for IVF treatment, Turkey offers some attractive reasons to travel to the country for the procedure.

What is the most expensive part of IVF? ›

Using a gestational carrier is the most expensive of all IVF options. If you include all the legal fees, agency fees, IVF costs, and payment to the gestational carrier, the cost can range anywhere between $50,000 to $100,000.

Who is 1 in 6 infertility? ›

About 17% of people experience infertility at some point during their lifetime, according to a World Health Organization (WHO) report that analyzed 133 studies.

What is the number one cause of infertility? ›

The most common overall cause of female infertility is the failure to ovulate, which occurs in 40% of women with infertility issues. Not ovulating can result from several causes, such as: Ovarian or gynecological conditions, such as primary ovarian insufficiency (POI) or polycystic ovary syndrome (PCOS)

Why are so many men infertile? ›

The most common issues that lead to infertility in men are problems that affect how the testicl*s work. Other problems are hormone imbalances or blockages or absence of some of the ducts in the male reproductive organs. Lifestyle factors and age-related factors also play a role in male infertility.

Is the US fertility rate declining? ›

The general fertility rate in the United States decreased by 3% from 2022, reaching a historic low.

Why is human fertility declining? ›

The social structure, religious beliefs, economic prosperity and urbanisation within each country are likely to affect birth rates as well as abortion rates, Developed countries tend to have a lower fertility rate due to lifestyle choices associated with economic affluence where mortality rates are low, birth control ...

Why is it so hard to get pregnant in the US? ›

Lots of factors can cause fertility problems, including: hormonal (endocrine) disorders, such as polycystic ovary syndrome (PCOS) and problems with the thyroid or pituitary glands. physical disorders, such as obesity, anorexia nervosa or excessive exercise.

What US state has the highest fertility rate? ›

1: South Dakota. South Dakota had a total of 11,201 births in 2022. It had the highest birth rate in the U.S. among women ages 25 to 29, at 136.2 per 1,000.


Top Articles
Latest Posts
Article information

Author: Aron Pacocha

Last Updated:

Views: 5855

Rating: 4.8 / 5 (68 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Aron Pacocha

Birthday: 1999-08-12

Address: 3808 Moen Corner, Gorczanyport, FL 67364-2074

Phone: +393457723392

Job: Retail Consultant

Hobby: Jewelry making, Cooking, Gaming, Reading, Juggling, Cabaret, Origami

Introduction: My name is Aron Pacocha, I am a happy, tasty, innocent, proud, talented, courageous, magnificent person who loves writing and wants to share my knowledge and understanding with you.